Free Trial
NASDAQ:MOVE

Movano Q4 2024 Earnings Report

Movano logo
$6.57 +0.08 (+1.23%)
Closing price 10/10/2025 03:59 PM Eastern
Extended Trading
$6.60 +0.04 (+0.53%)
As of 10/10/2025 06:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Movano EPS Results

Actual EPS
-$6.10
Consensus EPS
-$9.70
Beat/Miss
Beat by +$3.60
One Year Ago EPS
N/A

Movano Revenue Results

Actual Revenue
$0.11 million
Expected Revenue
$1.50 million
Beat/Miss
Missed by -$1.39 million
YoY Revenue Growth
N/A

Movano Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Wednesday, April 9, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Movano's Q3 2025 earnings is scheduled for Thursday, November 13, 2025, with a conference call scheduled on Friday, November 14, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Movano Earnings Headlines

Magnificent 7 being replaced by the “Hidden 7”?
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on some of the biggest winners of 2025.tc pixel
Alibaba’s Stock Dips Amid Strategic Moves
Coinbase Global Faces Stock Slump Amid Strategic Moves
See More Movano Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Movano? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Movano and other key companies, straight to your email.

About Movano

Movano (NASDAQ:MOVE) Health, Inc. (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality. The ring communicates wirelessly with a companion mobile application, where users can view detailed daily reports, set personalized health goals, and share data securely with healthcare providers or loved ones. By combining hardware design with cloud-based analytics, Movano aims to deliver actionable insights that support preventive care and early intervention.

To advance its platform, Movano collaborates with academic institutions, clinical researchers and technology partners. These collaborations help validate sensor accuracy, refine algorithms and explore new applications in areas such as women’s health, chronic disease management and fitness optimization. The company’s development roadmap includes pursuing regulatory clearances and expanding integrations with electronic health record systems.

Led by a management team with combined expertise in medical devices, consumer electronics and software development, Movano serves customers primarily in North America and is exploring opportunities for expansion into international markets. The company continues to invest in research and development to enhance its sensor suite and broaden its suite of health-monitoring solutions for both consumers and healthcare professionals.

View Movano Profile

More Earnings Resources from MarketBeat